Recombinant antihemophilic factor, porcine sequence. Historically, porcine factor VIII has provided a good effect. A porcine sequence recombinant FVIII (rpFVIII; Obizur) was approved by the US Food and Drug Administration (FDA) in 2014 for treatment of bleeding episodes in adults with acquired hemophilia.
FBI Reform - fbireform.comFBI Reform - fbireform.com - The News And Times